Lilly to launch multi-dose weight-loss drug device in US
Lilly to launch multi-dose weight-loss drug device in US is drawing significant interest across the industry.
Eli Lilly said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, delivering a full month of the treatment in a...
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Delone Catholic falls to Susquehanna Township in District 3 4A final
- Accelerating Solar Initiatives in Andhra Pradesh: A Government Push
- Service restored to 45% of affected homes after Beltsville gas leak explosion on Friday
- Coles 'down down' prices duped customers, court told
Source: Original →